輸入代號或公司名稱後按 Enter
4106

雃博

0.00 (0.00%)最後更新 2026-09-15
台灣 · 上市 · 生技醫療業
24.4047成交張數13.26本益比0.97股價淨值比4.10%殖利率2026-09-15資料日期

綜合損益表公開資訊觀測站申報原值 · 年度(第 4 季累計) · 每一格 = 該科目 ÷ 營業收入

營業收入20252,404年增 +0.7%
毛利率202545.9%最新一期
營業利益率20256.3%最新一期
每股盈餘20251.20年增 +5.3%
會計項目走勢20212022202320242025
營業收入合計100.0%100.0%100.0%100.0%100.0%
營業成本合計58.4%60.0%57.0%55.0%54.1%
營業毛利(毛損)41.6%40.0%43.0%45.0%45.9%
營業毛利(毛損)淨額41.6%40.0%43.0%45.0%45.9%
推銷費用15.6%14.2%14.3%16.3%16.4%
管理費用15.3%13.0%15.1%15.7%16.5%
研究發展費用6.3%5.8%6.3%6.9%6.4%
預期信用減損損失(利益)-0.0%0.0%-0.0%0.6%0.3%
營業費用合計37.2%33.1%35.7%39.5%39.6%
營業利益(損失)4.4%6.9%7.3%5.5%6.3%
利息收入0.1%0.1%0.2%0.4%0.3%
其他收入0.0%0.0%0.0%0.0%0.0%
其他利益及損失淨額1.6%0.8%0.9%0.9%1.0%
財務成本淨額0.3%0.4%0.5%0.5%0.6%
採用權益法認列之關聯企業及合資損益之份額淨額0.0%0.0%-0.0%-0.0%-0.0%
營業外收入及支出合計1.4%0.6%0.6%0.7%0.7%
稅前淨利(淨損)5.8%7.5%7.9%6.2%6.9%
所得稅費用(利益)合計1.5%1.4%2.1%1.3%1.9%
繼續營業單位本期淨利(淨損)4.4%6.1%5.8%4.8%5.1%
本期淨利(淨損)4.4%6.1%5.8%4.8%5.1%
確定福利計畫之再衡量數0.1%0.2%0.0%0.1%0.1%
透過其他綜合損益按公允價值衡量之權益工具投資未實現評價損益-0.1%0.1%0.1%-0.0%-0.1%
與不重分類之項目相關之所得稅0.0%0.0%0.0%0.0%0.0%
不重分類至損益之項目:-0.1%0.3%0.1%0.1%-0.1%
國外營運機構財務報表換算之兌換差額-3.7%1.9%1.7%1.9%2.8%
後續可能重分類至損益之項目:-3.7%1.9%1.7%1.9%2.8%
其他綜合損益(淨額)-3.8%2.1%1.7%2.0%2.7%
本期綜合損益總額0.6%8.2%7.5%6.8%7.8%
母公司業主(淨利∕損)4.3%6.1%5.7%4.8%5.0%
非控制權益(淨利∕損)0.1%0.0%0.0%0.0%0.0%
母公司業主(綜合損益)0.5%8.2%7.6%6.8%8.0%
非控制權益(綜合損益)0.0%0.0%-0.1%0.0%-0.2%
基本每股盈餘0.0%0.1%0.1%0.0%0.0%
稀釋每股盈餘0.0%0.1%0.1%0.0%0.0%
銷貨收入淨額100.0%100.0%100.0%100.0%
銷貨成本58.4%60.0%57.0%55.0%

金額為公司申報原值除以一千(百萬元,四捨五入),每股金額為元。年度為第 4 季的年初至今累計數。走勢條是歷史各期的相對大小,藍為正、綠為負。年增以去年同期為基期,基期非正數或變動超過十倍時不列。 權益變動表在申報資料分頁。